Cited by 925Birth, Development, and HealthPancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Type 2 diabetes across generations: from pathophysiology to prevention and management

Nolan, Christopher J, Damm, Peter, Prentki, Marc·2011·The Lancet

Abstract

Type 2 diabetes is now a pandemic and shows no signs of abatement. In this Seminar we review the pathophysiology of this disorder, with particular attention to epidemiology, genetics, epigenetics, and molecular cell biology. Evidence is emerging that a substantial part of diabetes susceptibility is acquired early in life, probably owing to fetal or neonatal programming via epigenetic phenomena. Maternal and early childhood health might, therefore, be crucial to the development of effective prevention strategies. Diabetes develops because of inadequate islet β-cell and adipose-tissue responses to chronic fuel excess, which results in so-called nutrient spillover, insulin resistance, and metabolic stress. The latter damages multiple organs. Insulin resistance, while forcing β cells to work harder, might also have an important defensive role against nutrient-related toxic effects in tissues such as the heart. Reversal of overnutrition, healing of the β cells, and lessening of adipose tissue defects should be treatment priorities.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(11)60614-4

Cites

146 of 146 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The liver does not seem to be a primary pathogenic driver of T2DM or GDM.

    “Despite this, the liver does not seem to be a primary pathogenic driver of T2DM or GDM [123].”

    From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [123]

  • Attempts to directly reverse skeletal muscle insulin resistance, without reducing plasma glucose concentrations, could be detrimental.

    “This is an important distinction when considering potential treatments for GDM: attempts to directly reverse skeletal muscle insulin resistance, without reducing plasma glucose concentrations, could be detrimental [123].”

    From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [123]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nolan, C. J., Damm, P., & Prentki, M.
Affiliations
  • Australian National University (AU)
  • University of Copenhagen (DK)
  • Université de Montréal (CA)
Corresponding author
Nolan, Christopher J
Venue
The Lancet
Publisher
Elsevier BV
Published
2011-07
Volume
378
Issue
9786
Pages
169-181
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2156472431
Cited by
923
References
146
Citations by year
2026: 13 · 2025: 23 · 2024: 43 · 2023: 42 · 2022: 54 · 2021: 60 · 2020: 57 · 2019: 58 · 2018: 58 · 2017: 55 · 2016: 93 · 2015: 86 · 2014: 104 · 2013: 90 · 2012: 78
FWCI
13.41
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
  • ANU Open Research (Australian National University) (submittedVersion)
Funders
  • Novo Nordisk
  • Novo Nordisk Fonden
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, pathophysiology, insulin resistance, beta-cell dysfunction, adipose tissue dysfunction, metabolic stress, epigenetics, fetal programming, neonatal programming, genetic susceptibility, diabetes prevention, diabetes management, overnutrition, maternal health, early childhood health
MeSH terms
Adipose Tissue, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Female, Glucagon, Homeostasis, Humans, Insulin Resistance, Life Style, Liver, Myocardium, Obesity, Prediabetic State, Pregnancy, Diabetes, Gestational, Muscle, Skeletal, Genetic Predisposition to Disease, Epigenesis, Genetic, Fetal Development, Insulin-Secreting Cells, Glucagon-Like Peptide 1, Incretins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review